As stated on the project disclosure page, the proposed IFC investment seeks to support Institut Pasteur de Dakar scale up vaccine production capacity in Africa and manufacture up to 300 million doses of vaccines per year. This will be achieved through the construction of a multi-vaccines plant in Diamniadio, Senegal providing for drug substance manufacturing and fill & finish capacities.
The Project is expected to help address the critical supply gap of vaccines in Africa as it creates additional manufacturing capacities and is expected to contribute to meeting the continent’s future needs for vaccines. The Project is expected to help strengthen the future resilience of the region health systems and supply chain and reduce the continent dependence on imports.
As stated by the IFC, the remaining Project costs is expected to be funded through a mix of grant and public financing.
As stated by the IFC, IPD is a biomedical research center and vaccine manufacturer created in 1923. It is a private not-for-profit foundation under Senegalese law. IPD was jointly created and is jointly managed by the Government of Senegal and Institut Pasteur, France. IPD’s mission is to contribute to public health in Africa, especially in Senegal, through research, teaching, medical, epidemiological, and biological training, as well as vaccine production.
The Project is expected to be implemented through a Project special purpose vehicle to be established and to be majority owned by IPD.
|Private Actor 1
|Private Actor 1 Role
|Private Actor 1 Sector
|Private Actor 2
|Private Actor 2 Role
|Private Actor 2 Sector
|Institut Pasteur de Dakar
|Education and Health
General IFC Inquiries - IFC Communications:
Address: 2121 Pennsylvania Avenue, NW, Washington DC 20433
Telephone: +1 202-473-3800
Fax: +1 202-974-4384
Client - Institut Pasteur de Dakar:
Mohamed P. Ndiaye - Senior advisor for strategy, planning & financing
Address and Local Access for Project Documentation: 36 Avenue Pasteur, Dakar, Senegal
ACCESS TO INFORMATION
You can submit a request for information disclosure at: https://disclosures.ifc.org/#/inquiries
If you believe that your request for information from IFC has been unreasonably denied, or that this Policy has been interpreted incorrectly, you can submit a complaint at the link above to IFC's Access to Information Policy Advisor, who reports directly to IFC's Executive Vice President.
ACCOUNTABILITY MECHANISM OF IFC/MIGA
The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at CAO@worldbankgroup.org You can learn more about the CAO and how to file a complaint at http://www.cao-ombudsman.org